Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Beard

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 15, 2017
Measuring fetal brain and lung transcripts in amniotic fluid supernatant: a comparison of digital PCR and RT-qPCR methodsLisa Hui, Sally Beard, Natalie J Hannan
Future Microbiology|April 14, 2016
Organism-wide studies into pathogenicity and morphogenesis in Talaromyces marneffeiHarshini Weerasinghe, Michael Payne, Sally Beard, et al.
Pregnancy Hypertension|November 21, 2017
sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: Are they interchangeable for biomarker studies?Fiona Brownfoot, Tu'uhevaha Kaitu'u-Lino, Sally Beard, et al.
Plos One|November 23, 2022
Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitroElif Kadife, Natalie Hannan, Alesia Harper, et al.
Plos One|April 12, 2018
Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsiaNatalie J Hannan, Natalie K Binder, Sally Beard, et al.
Gynecologic Oncology Reports|January 10, 2022
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancerNatalie J Hannan, Paul A Cohen, Sally Beard, et al.
Placenta|May 6, 2021
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissuesFiona Brownfoot, Natalie Binder, Roxanne Hastie, et al.
Biomedical Reports|April 29, 2017
The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancerAdam Pendlebury, Natalie J Hannan, Natalie Binder, et al.
Placenta|September 27, 2020
Novel approaches to combat preeclampsia: from new drugs to innovative deliveryNatasha de Alwis, Natalie K Binder, Sally Beard, et al.
Pregnancy Hypertension|June 25, 2015
Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglinTu'uhevaha J Kaitu'u-Lino, Stephen Tong, Sally Beard, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 15, 2017
Measuring fetal brain and lung transcripts in amniotic fluid supernatant: a comparison of digital PCR and RT-qPCR methodsLisa Hui, Sally Beard, Natalie J Hannan
Future Microbiology|April 14, 2016
Organism-wide studies into pathogenicity and morphogenesis in Talaromyces marneffeiHarshini Weerasinghe, Michael Payne, Sally Beard, et al.
Pregnancy Hypertension|November 21, 2017
sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: Are they interchangeable for biomarker studies?Fiona Brownfoot, Tu'uhevaha Kaitu'u-Lino, Sally Beard, et al.
Plos One|November 23, 2022
Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitroElif Kadife, Natalie Hannan, Alesia Harper, et al.
Plos One|April 12, 2018
Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsiaNatalie J Hannan, Natalie K Binder, Sally Beard, et al.
Gynecologic Oncology Reports|January 10, 2022
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancerNatalie J Hannan, Paul A Cohen, Sally Beard, et al.
Placenta|May 6, 2021
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissuesFiona Brownfoot, Natalie Binder, Roxanne Hastie, et al.
Biomedical Reports|April 29, 2017
The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancerAdam Pendlebury, Natalie J Hannan, Natalie Binder, et al.
Placenta|September 27, 2020
Novel approaches to combat preeclampsia: from new drugs to innovative deliveryNatasha de Alwis, Natalie K Binder, Sally Beard, et al.
Pregnancy Hypertension|June 25, 2015
Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglinTu'uhevaha J Kaitu'u-Lino, Stephen Tong, Sally Beard, et al.
Pageof 5